Expression of ADAM9 in CIN3 lesions and squamous cell carcinomas of the cervix.
about
Clinical significance of ADAM10 expression in laryngeal carcinoma.A disintegrin and metalloproteinase 9 is involved in ectodomain shedding of receptor-binding cancer antigen expressed on SiSo cells.Inhibiting adenoid cystic carcinoma cells growth and metastasis by blocking the expression of ADAM 10 using RNA interference.Effects of ADAM10 upregulation on progression, migration, and prognosis of nasopharyngeal carcinoma.ADAM9 Expression Is Associate with Glioma Tumor Grade and Histological Type, and Acts as a Prognostic Factor in Lower-Grade GliomasDifferentially expressed microRNAs in the serum of cervical squamous cell carcinoma patients before and after surgery.Aberrant expression of disintegrin-metalloprotease proteins in the formation and progression of uterine cervical cancer.High expression of a disintegrin and metalloproteinase-9 predicts a shortened survival time in completely resected stage I non-small cell lung cancer.Overexpression of ADAM9 in oral squamous cell carcinoma.Loss of ADAM9 expression impairs β1 integrin endocytosis, focal adhesion formation and cancer cell migration.Sorting nexin 9 (SNX9) regulates levels of the transmembrane disintegrin and metalloproteinase (ADAM)-9 at the cell surface.A disintegrin and metalloprotease (ADAM)10 is highly expressed in hepatocellular carcinoma and is associated with tumour progression.
P2860
Q33597779-4519F824-3293-41DD-B92C-3A5183EC600BQ34079881-359D66EB-0AAD-488F-85B6-68AC51BC4FE7Q34473664-2642B3C3-C944-47EF-8B6E-4A603D04B86EQ36467413-2940D885-8830-4854-BE89-97A542794CAAQ37286187-54AE9CB6-4F9E-458D-B18A-AE0C38681A23Q37479781-ABCA9D31-D246-4BDA-A641-A4BD9D34C3A4Q39536282-4E0F7577-1537-4203-B0BD-CDCC4F4B211FQ42149506-5498E519-DA40-45AE-AD15-F7CA84C0C928Q47162764-4AB6E88E-2B3C-44FC-AE0A-3672BFC3E641Q47590431-7C1AAA2C-A10C-4292-9146-5DABA3472750Q52603837-16A0A093-DE07-4AEA-9668-39126040B29CQ54216177-DFBD886D-3101-4BF4-9904-CBB8A001725A
P2860
Expression of ADAM9 in CIN3 lesions and squamous cell carcinomas of the cervix.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Expression of ADAM9 in CIN3 lesions and squamous cell carcinomas of the cervix.
@ast
Expression of ADAM9 in CIN3 lesions and squamous cell carcinomas of the cervix.
@en
type
label
Expression of ADAM9 in CIN3 lesions and squamous cell carcinomas of the cervix.
@ast
Expression of ADAM9 in CIN3 lesions and squamous cell carcinomas of the cervix.
@en
prefLabel
Expression of ADAM9 in CIN3 lesions and squamous cell carcinomas of the cervix.
@ast
Expression of ADAM9 in CIN3 lesions and squamous cell carcinomas of the cervix.
@en
P2093
P1433
P1476
Expression of ADAM9 in CIN3 lesions and squamous cell carcinomas of the cervix.
@en
P2093
Angel Alonso
Angela Zubel
Christa Flechtenmacher
Lutz Edler
P304
P356
10.1016/J.YGYNO.2009.05.005
P407
P577
2009-05-27T00:00:00Z